Skip to main content
Atrás
Watch Compare

Celularity Inc

Calidad de datos: 100%
También listada como CELUW NASDAQ
CELU
NASDAQ Manufacturing Chemicals
$1.24
▼ $0.01 (-0.80%)
6 months return
—
Momentum
Neutral
Net margin
-198.75%

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)138.11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROIC-76.69%
Net Margin-198.75%
Op. Margin-119.60%

Seguridad

Debt / Equity
N/A
Current Ratio0.16
Interest CoverageN/A

Valoración

PE (TTM)
-0.48
Above sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -6.68 M
Capital efficient — spends only 0.31% of revenue on capex

Price History

Tendencias Financieras

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Sorpresas de Ganancias

EPS
Reported Estimate
Q12023 Q22023
Reported -$4.10 -$2.70
Estimate -$2.40 -$0.30
Sorpresa -70.83% -800.00%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 138.11% Revenue Growth (3Y) 73.68%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: -198.75%
Revenue (TTM) 40.58 M Net Income (TTM) -80.65 M
ROE N/A ROA -68.78%
Gross Margin N/A Operating Margin -119.60%
Net Margin -198.75% Free Cash Flow (TTM) -6.68 M
ROIC -76.69% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0.16
Debt / Equity N/A Current Ratio 0.16
Interest Coverage N/A Asset Turnover 0.35
Working Capital -54.72 M Tangible Book Value -35.57 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.48 · EV/EBITDA: N/A
P/E Ratio -0.48 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.96
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -17.17%
Market Cap 38.93 M Enterprise Value 38.81 M

Per Share

EPS: -3.33 · FCF/Share: -0.23
EPS (Diluted TTM) -3.33 Revenue / Share 1.41
FCF / Share -0.23 OCF / Share -0.23
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 8.29% · CapEx/Rev: 0.31%
CapEx / Revenue 0.31% FCF Conversion 8.29%
SBC-Adj. FCF -7.47 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 54.22 M 22.77 M 17.98 M 21.34 M —
Net Income -57.89 M -196.30 M 14.19 M -100.12 M -2.63 M
EPS (Diluted) -2.64 -11.02 0.09 — —
Gross Profit — 6.76 M -1.69 M 11.68 M —
Operating Income -38.36 M -192.29 M -25.60 M -109.06 M -4.22 M
EBITDA — — — — —
R&D Expenses 17.39 M 30.47 M 78.36 M 88.35 M —
SG&A Expenses 58.64 M 50.58 M 66.02 M 71.34 M —
D&A 7.92 M 9.32 M 9.44 M 8.82 M —
Interest Expense — — — — —
Income Tax 10,000.0 10,000.0 13,000.0 20,000.0 191,644.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 132.68 M 143.89 M 401.07 M 414.13 M 292.16 M
Total Liabilities 123.85 M 102.93 M 202.17 M 314.71 M 14.22 M
Shareholders' Equity 8.84 M 40.96 M 198.90 M 99.42 M 5.00 M
Total Debt — 17.22 M 37.60 M — —
Cash & Equivalents 738,000.0 227,000.0 13.97 M 37.24 M 314,696.0
Current Assets 20.56 M 19.79 M 33.50 M 59.10 M 359,289.0
Current Liabilities 53.68 M 67.30 M 62.09 M 26.23 M 3.41 M

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E -0.5 -1.5
P/B — 1.6
ROE % — -54.7
Net Margin % -198.8 -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3

Puntuaciones de Estrategias

1 strategy matched
Value Price/Sales Ratio Focus (Ken Fisher)
#71 of 245
69

Actividad Reciente

Entró Price/Sales Ratio Focus (Ken Fisher)
Apr 12, 2026